Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Assets: 2017-2021

Historic Other Non-Current Assets for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $2.0 million.

  • Cogent Biosciences' Other Non-Current Assets rose 62.23% to $2.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 million, marking a year-over-year increase of 62.23%. This contributed to the annual value of $1.3 million for FY2020, which is negligibly% changed negligibly from last year.
  • Cogent Biosciences' Other Non-Current Assets amounted to $2.0 million in Q3 2021, which was up 3.35% from $2.0 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Other Non-Current Assets ranged from a high of $2.6 million in Q1 2018 and a low of $1.3 million during Q2 2018.
  • For the 3-year period, Cogent Biosciences' Other Non-Current Assets averaged around $1.4 million, with its median value being $1.3 million (2021).
  • As far as peak fluctuations go, Cogent Biosciences' Other Non-Current Assets plummeted by 51.95% in 2019, and later spiked by 62.23% in 2021.
  • Quarterly analysis of 5 years shows Cogent Biosciences' Other Non-Current Assets stood at $1.4 million in 2017, then decreased by 8.59% to $1.3 million in 2018, then remained steady at $1.3 million in 2019, then remained steady at $1.3 million in 2020, then soared by 62.23% to $2.0 million in 2021.
  • Its Other Non-Current Assets was $2.0 million in Q3 2021, compared to $2.0 million in Q2 2021 and $1.3 million in Q1 2021.